Partnering with Shionogi USA

Shionogi & Co., Ltd. has a history of successful collaborations with pharmaceutical industry players of all sizes, including AstraZeneca, Aguoron (now part of Pfizer), and Eli Lilly. These collaborations vary in structure, from in-licensing and out-licensing deals to longer-term partnerships.

In the US, the Shionogi-GlaxoSmithKline joint venture is an example of a ground-breaking deal structure that addresses each company’s unique strategic objectives. Many of Shionogi USA, Inc.’s clinicians and project managers support the clinical development activities within this joint-venture.

Together with our corporate parent, Shionogi & Co., Ltd, Shionogi USA continues to be interested in exploring additional business development opportunities, including product in-licensing arrangements. To discuss a business development opportunity, please send an email to partnering@shionogi-usa.com with a description of the potential collaboration.